• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

软组织填充剂注射相关的即将发生的坏死的处理

Management of impending necrosis associated with soft tissue filler injections.

作者信息

Dayan Steven H, Arkins John P, Mathison Clyde C

机构信息

Chicago Center for Facial Plastic Surgery, Chicago, IL 60611, USA.

出版信息

J Drugs Dermatol. 2011 Sep;10(9):1007-12.

PMID:22052269
Abstract

BACKGROUND

As the number of soft tissue filler injections increases, the number of adverse events associated with injection may rise. Impending necrosis represents a serious complication that, if not treated correctly and timely, may have grave consequences.

OBJECTIVE

We describe a protocol utilizing hyaluronidase, nitroglycerin paste, aspirin, antacid and a topical oxygen therapy that may be used to treat impending necrosis subsequent to injection with soft tissue fillers.

CONCLUSION

We have successfully treated nine post-filler injection adverse events involving impending necrosis or necrosis following both hyaluronic acid and calcium hydroxylapatite injections using our protocol.

摘要

背景

随着软组织填充剂注射数量的增加,与注射相关的不良事件数量可能会上升。即将发生的坏死是一种严重的并发症,如果没有得到正确及时的治疗,可能会产生严重后果。

目的

我们描述了一种使用透明质酸酶、硝酸甘油糊剂、阿司匹林、抗酸剂和局部氧疗的方案,可用于治疗软组织填充剂注射后即将发生的坏死。

结论

我们使用该方案成功治疗了9例填充剂注射后的不良事件,这些事件涉及透明质酸和羟基磷灰石钙注射后即将发生的坏死或坏死。

相似文献

1
Management of impending necrosis associated with soft tissue filler injections.软组织填充剂注射相关的即将发生的坏死的处理
J Drugs Dermatol. 2011 Sep;10(9):1007-12.
2
Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase.透明质酸软组织填充术后迟发性临近坏死的表现及透明质酸酶成功治疗
J Drugs Dermatol. 2007 Mar;6(3):325-8.
3
Extensive necrosis after injection of hyaluronic acid filler: case report and review of the literature.注射透明质酸填充物后广泛坏死:病例报告及文献复习。
J Cosmet Dermatol. 2011 Sep;10(3):224-31. doi: 10.1111/j.1473-2165.2011.00562.x.
4
Intralesional hyaluronidase injection to relieve non-hyaluronic acid filler-induced vascular adverse events.瘤内注射透明质酸酶以缓解非透明质酸填充剂引起的血管不良事件。
Int J Dermatol. 2024 Sep;63(9):1252-1255. doi: 10.1111/ijd.17355. Epub 2024 Jul 2.
5
Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management.透明质酸填充剂的血管并发症及透明质酸酶在其治疗中的作用。
J Plast Reconstr Aesthet Surg. 2011 Dec;64(12):1590-5. doi: 10.1016/j.bjps.2011.07.013. Epub 2011 Jul 31.
6
Fillers impacting follicles: the emerging complication of filler-induced alopecia.影响毛囊的填充物:填充物诱导脱发的新兴并发症。
Int J Dermatol. 2024 Sep;63(9):1131-1139. doi: 10.1111/ijd.17169. Epub 2024 Apr 14.
7
Complications associated with injectable soft-tissue fillers: a 5-year retrospective review.注射用软组织填充剂相关并发症:一项 5 年回顾性研究。
JAMA Facial Plast Surg. 2013 May;15(3):226-31. doi: 10.1001/jamafacial.2013.798.
8
Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid.办公室中的透明质酸酶:每位注射透明质酸的皮肤外科医生的必备品。
J Cosmet Laser Ther. 2007 Sep;9(3):182-5. doi: 10.1080/14764170701291674.
9
A problem-oriented approach to nodular complications from hyaluronic acid and calcium hydroxylapatite fillers: classification and recommendations for treatment.一种针对透明质酸和羟磷灰石填充剂结节性并发症的以问题为导向的处理方法:分类和治疗建议。
Plast Reconstr Surg. 2013 Oct;132(4 Suppl 2):48S-58S. doi: 10.1097/PRS.0b013e31829e52a7.
10
Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations.面部美学中可逆性与非可逆性填充剂:关注点与考量因素
Dermatol Online J. 2008 Aug 15;14(8):3.

引用本文的文献

1
Arterioembolic Characteristics of Differentially Diluted CaHA-CMC Gels Within An Artificial Macrovascular Perfusion Model.人工大血管灌注模型中不同稀释度的羟基磷灰石-羧甲基纤维素凝胶的动脉栓塞特性
Aesthet Surg J. 2025 May 15;45(6):645-653. doi: 10.1093/asj/sjaf028.
2
Complications of Nonsurgical Rhinoplasty with Hyaluronic Acid Injections: A Narrative Review.透明质酸注射非手术隆鼻的并发症:一项叙述性综述
Aesthetic Plast Surg. 2025 Jan 2. doi: 10.1007/s00266-024-04636-4.
3
Efficacy and Safety of Fillers for the Treatment of Nasolabial Folds: A Network meta-Analysis of Randomized Controlled Trials.
填充剂治疗鼻唇沟皱纹的疗效和安全性:一项随机对照试验的网络荟萃分析。
Aesthetic Plast Surg. 2024 Sep;48(17):3452-3462. doi: 10.1007/s00266-024-03889-3. Epub 2024 Apr 10.
4
Managing intravascular complications following treatment with calcium hydroxylapatite: An expert consensus.羟基磷灰石治疗后血管内并发症的管理:专家共识
J Cosmet Dermatol. 2020 Nov;19(11):2845-2858. doi: 10.1111/jocd.13353. Epub 2020 Mar 17.
5
Management of a Vascular Occlusion Associated with Cosmetic Injections.与美容注射相关的血管闭塞的管理。
J Clin Aesthet Dermatol. 2020 Jan;13(1):E53-E58. Epub 2020 Jan 1.
6
Miliary microemboli of the retinal arterioles and choriocapillaris after subcutaneous injection of triamcinolone acetonide.皮下注射曲安奈德后视网膜小动脉和脉络膜毛细血管的粟粒状微栓子
J Curr Ophthalmol. 2018 Jul 3;31(1):98-101. doi: 10.1016/j.joco.2018.06.007. eCollection 2019 Mar.
7
Effectiveness of Low Doses of Hyaluronidase to Remove Hyaluronic Acid Filler Nodules: A Randomized Clinical Trial.低剂量透明质酸酶去除透明质酸填充结节的有效性:一项随机临床试验。
JAMA Dermatol. 2018 Jul 1;154(7):765-772. doi: 10.1001/jamadermatol.2018.0515.
8
Transparency and Dermatologic Device Approval by the US Food and Drug Administration.透明度与美国食品和药物管理局批准的皮肤科医疗器械
JAMA Dermatol. 2018 Mar 1;154(3):273-280. doi: 10.1001/jamadermatol.2017.5757.
9
Cerebral Angiographic Findings of Cosmetic Facial Filler-related Ophthalmic and Retinal Artery Occlusion.美容面部填充剂相关的眼动脉和视网膜动脉阻塞的脑血管造影表现
J Korean Med Sci. 2015 Dec;30(12):1847-55. doi: 10.3346/jkms.2015.30.12.1847. Epub 2015 Nov 30.
10
Treatment algorithm of complications after filler injection: based on wound healing process.填充剂注射后并发症的治疗算法:基于伤口愈合过程。
J Korean Med Sci. 2014 Nov;29 Suppl 3(Suppl 3):S176-82. doi: 10.3346/jkms.2014.29.S3.S176. Epub 2014 Nov 21.